Testing the utility of a cancer clinical trial specific Question Prompt List (QPL-CT) during oncology consultations

Patient Education and Counseling

Volumn 88, Issue 2, 2012, Pages 311-317

  Brown, Richard F ^a   Bylund, Carma L ^b   Li, Yuelin ^b   Edgerson, Shawna ^b   Butow, Phyllis ^c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Clinical Trials; Physician patient communication; Question Prompt Lists

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CLINICAL ARTICLE; CONSULTATION; DOCTOR PATIENT RELATION; FEMALE; HEALTH SERVICE; HUMAN; LUNG CANCER; MALE; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEDICAL PRACTICE; ONCOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUESTION PROMPT LIST FOR CLINICAL TRIALS; QUESTIONNAIRE; UROGENITAL TRACT CANCER;

ADULT; AGED; AGED, 80 AND OVER; CLINICAL TRIALS AS TOPIC; COMMUNICATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NEW YORK CITY; PATIENT PARTICIPATION; PATIENT SATISFACTION; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES; REFERRAL AND CONSULTATION; REMINDER SYSTEMS; REPRODUCIBILITY OF RESULTS; SOCIOECONOMIC FACTORS;

EID: 84864344885     PISSN: 07383991     EISSN: 18735134     Source Type: Journal    
DOI: 10.1016/j.pec.2012.02.009     Document Type: Article

References (45)

1. Brown R., Butow P.N., Tattersall M.H.N. Promoting patient participation in the cancer consultation: evaluation of a prompt sheet and coaching in question-asking. Br J Cancer 1999, 80:242-248.
2. Brown R.F., Butow P., Dunn S., Tattersall M.H. Promoting patient participation and shortening cancer consultations: a randomized trial. Br J Cancer 2001, 85:1273-1279.
3. Butow P.N., Dunn S.M., Tattersall M.H.N., Jones Q.J. Patient involvement in the cancer consultation; evaluation of a question prompt sheet. Ann Oncol 1994, 5:199-204.
4. Kaplan S.H., Greenfield S., Gandek B., Rogers W.H., Ware J.E. Characteristics of physicians with participatory decision making styles. Ann Intern Med 1996, 124:497-504.
5. Epstein R.M., Street R.L. Patient-centered communication in cancer care: promoting healing and reducing suffering. Vol. NIH Publication No 07-6225 2007, National Cancer Institute, Bethesda, MD.
6. Roter D. Patient participation in the patient-provider interaction: the effects of patient question asking on the quality of interaction, satisfaction and compliance. Health Educ Monogr 1977, 5:281-315.
7. Clayton J., Butow P., Tattersall M.H.N., Chye R., Noel M., Davis J.M., et al. Asking questions can help: development and preliminary evaluation of a question prompt list for palliative care patients. Br J Cancer 2003, 89:2069-2077.
8. McJannett M., Butow P., Tattersall M.H.N., Thompson J.F. Asking questions can help: development of a question prompt list for cancer patients seeing a surgeon. Eur J Cancer Prev 2003, 12:397-405.
9. Demoska A, Butow PN, Lynch J, Hovey E, Agar M, Beale P, et al. Implementing patients question prompt lists into routine cancer care. Patient Educ Couns, doi:10.1016/pec.2011.04.020.
10. Geest T.A., Wetzels R., Wensing M., Castel O.C., Olsen F. Evaluation of an intervention designed to enhance involvement of older patients in their own care. Eur J Gen Pract 2006, 12:3-9.
11. Agrawal M., Grady C., Fairclough D.L., Meropol N.J., Maynard K., Emanuel E.J. Patient decision making process regarding participation in Phase I oncology research. J Clin Oncol 2006, 24:4479-4483.
12. Albrecht T.L., Penner L.A., Cline R.J.W., Eggly S., Ruckdeschel J.C. Studying the process of clinical communication: issues of context, concepts and research directions. J Health Commun 2009, 14:47-56.
13. Albrecht T.L., Ruckdeschel J.C., Riddle J.C., Blanchard C.G., Penner L.A., Coovert M.D., et al. Communication and decision making about cancer clinical trials. Patient Educ Couns 2003, 50:39-42.
14. Brown R.F., Butow P.N., Ellis P., Boyle F., Tattersall M.H.N. Seeking informed consent to cancer clinical trials: describing current practice. Soc Sci Med 2004, 58:2445-2457.
15. Brown R.F., Bylund C.L., Siminoff L.A., Slovin S.F. Seeking informed consent to Phase I cancer clinical trial: identifying oncologists' communication strategies. Psychooncology 2010, 20:361-368.
16. Fallowfield L., Jenkins V., Farewell V., Saul J., Duffy A., Eves R. Efficacy of a Cancer research UK communication skills training model for oncologists: a randomised controlled trial. Lancet 2002, 359:650-656.
17. Fallowfield L. Can we improve the professional personal fulfilment of doctors in cancer medicine. Br J Cancer 1995, 71:1132-1133.
18. Fallowfield L., Ratcliffe D., Souhami R.L. Clinicians' attitudes to clinical trials of cancer therapy. Eur J Cancer 1997, 33:2221-2229.
19. Hall A. The role of effective communication in obtaining informed consent in medical research 2001, 290-298. BMJ Books, London. L. Loyal, J.S. Tobias (Eds.).
20. Lee J.Y., Breaux S.R. Accrual of radiotherapy patients to clinical trials. Cancer 1983, 52:1014-1016.
21. Grossman S.A., Piantadosi S., Cohavey C. Are informed consent forms that describe clinical oncology research protocols readable by most patients and their families?. J Clin Oncol 1994, 12:2211-2215.
22. Albrecht T.L., Penner L.A., Ruckdeschel J.C. Understanding patient decisions about clinical trials and the associated communication processes; a preliminary report. J Cancer Educ 2003, 18:210-214.
23. Meropol N.J., Weinfurt C.B., Balshem A., Benson A.B., Castel L., Corbett S., et al. Perceptions of patients and physicians regarding Phase I cancer clinical trials: implications for physician-patient communication. J Clin Oncol 2003, 21:2589-2596.
24. Cox K. Informed consent and decision making: patients' experiences of the process of recruitment to phases 1 and 2 anti-cancer drug trials. Patient Educ Couns 2002, 46:31-38.
25. Cheng J.D., Hitt J., Koczwara B., Schulman K.A., Burnett C.B., Gaskin D.J., et al. Impact of quality of life on patient expectations regarding Phase I clinical trials. J Clin Oncol 2000, 18:421-428.
26. Daugherty C., Kass N.E., Roter D., Larson S., Sugarman J., Kasza M., et al. A study of physician investigator (PI) disclosure of alternatives of care and prognostic information to advanced cancer patients (ACP) enrolling in Phase I trials. J Clin Oncol 2009, 27. [abstract 6508].
27. Brown R.F., Butow P.N., Boyle F., Tattersall M.H.N. Seeking informed consent to cancer clinical trials: evaluating the efficacy of communication skills training. Psychooncology 2007, 16:507-516.
28. Brown R.F., Butow P.N., Butt D.G., Moore A.R., Tattersall M.H. Developing ethical strategies to assist oncologists in seeking informed consent to cancer clinical trials. Soc Sci Med 2004, 58:379-390.
29. Brown R.F., Shuk E., Butow P.N., Edgerson S., Tattersall M.H.N., Ostroff M.H.N. Identifying patient information needs about cancer clinical trials using a question prompt list. Patient Educ Couns 2011, 84:69-77.
30. Brown R.F., Shuk E., Butow P.N., Leighl N., Edgerson S., Ostroff J., et al. Enhancing decision making about participation in cancer clinical trials: development of a question prompt list. Support Care Cancer 2011, 19:1227-1238.
31. Cassileth B.R., Zupkis R.V., Sutton-Smith K., March V. Information and participation preferences among cancer patients. Ann Intern Med 1980, 92:832-836.
32. Strull W.M., Lo B., Charles G. Do patients want to participate in medical decision making?. J Am Med Assoc 1984, 252:2990-2994.
33. Degner L.F., Sloan J.A., Venkatech P. The control preferences scale. Can J Nurs Res 1997, 29:21-43.
34. Sutherland H.J., Llewellyn-Thomas H.A., Lockwood G.A., Tritchler D.L. Cancer patients: their desire for information and participation in treatment decisions. J R Soc Med 1989, 82(May):260-263.
35. Gattellari M., Butow P.N., Tattersall M.H. Sharing decisions in cancer care. Soc Sci Med 2001, 52:1865-1878.
36. Ford S., Schofield T., Hope T. Are patients' decision-making preferences being met?. Health Expect 2003, 6:72-80.
37. Mistry A., Wilson S., Priestman T., Damery S., Haque M. How do the information needs of cancer patients differ at different stages of the cancer journey? A cross-sectional survey. JRSM Short Rep 2010, 1.
38. Chewning B, Bylund LC, Shah B, Arora NK, Gueguen JA, Makoul G. Patient preferences for shared decision - a systematic review. Patient Educ Couns, doi:10.1016/j.pec.2011.02.004.
39. Cox A.C., Fallowfield L.J., Jenkins V.A. Communication and the informed consent process in Phase I trials: a review of the literature. Support Care Cancer 2006, 14:303-309.
40. Cohen L., de Moor C., Amato R.J. The Association between treatment specific optimism and depressive symptomatology in patients enrolled in a Phase I cancer clinical trial. Cancer 2001, 91:1949-1955.
41. Weinfurt K.P., Seils D.M., Tzeng J.P., Compton K.L., Sulmasy D.P., Astrow A.B., et al. Expectations of benefit in early phase clinical trials: Implications for assessing the adequacy of informed consent. Med Decis Making 2008, 28:575-581.
42. Itoh K., Sasaki Y., Fujii H., Ohtsu T., Wakita H., Igarashi T., et al. Patients in Phase I trials of anti cancer agents in Japan: motivation, comprehension and expectations. Br J Cancer 1997, 76:101-113.
43. Daugherty C.K., Ratain M.J., Siegler M. Pushing the envelope: informed consent to phase 1 trials. Ann Oncol 1995, 6:321-323.
44. Jenkins V.A., Anferson J.L., Fallowfield L.J. Communication and informed consent in Phase I trials: a review of literature from January 2005-July 2009. Support Care Cancer 2010, 18:1115-1121.
45. Leydon G.M., Boulton M., Moynihan C., Jones A., Mossman J., Boudioni M., et al. Cancer patients information needs and information seeking behavior: an in depth interview study. Br Med J 2000, 320:909-913.